JDD Multimedia

Best Practices & Practical Pearls for Safely Reopening Derm Practices

The Journal of Drugs in Dermatology (JDD)  is proud to present an essential education program on the topic of guidelines for safely reopening dermatology practices during the COVID-19 pandemic, lead by Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts and a panel of dermatology thought leaders.

This video series was produced by the Journal of Drugs in Dermatology and supported in part by Alastin Skincare, Endo Aesthetics. Ortho Dermatologics, and Sciton.

Supported in part by

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Jeffrey S. Dover

Discussion Topics

  • Medical Office Preparedness
  • Managing the Office Environment
  • General Guidance
  • Cleaning & Disinfecting Practices
  • Practices
  • PPE and Medical Supplies

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Kavita Mariwalla

Discussion Topics

  • Clinical and Non-Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Anesthesia and analgesia
  • Injectables

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Thomas E. Rohrer

Discussion Topics

  • Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Post-Surgery Follow Up

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Terrence Keaney

Discussion Topics

  • Non-invasive body contouring
  • Energy-based procedures of the face and neck
  • Skin treatment procedures

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Nazanin Saedi

Discussion Topics

  • Employee health and training
  • Recognition of symptoms
  • Symptomatic patients and employees
  • Office arrival, check-in and check-out
  • Pre-screening patients

You May Also Like

Journal of Drugs in Dermatology JDD Article About Social Media as a Catalyst for Health Education and Early Diagnosis of Hidradenitis Suppurativa. Image also from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. It features a lighter skin tone patient who has HS under arm.

Social Media as a Catalyst for Health Education and Early Diagnosis of Hidradenitis Suppurativa

| Featured Articles, Latest News, Social and Technology, The Latest | No Comments
Has TikTok Helped Your Patients Recognize Hidradenitis Suppurativa Sooner? You might have heard it from your own patients: “I saw a video on TikTok and realized I might have HS.”…
Journal of Drugs in Dermatology JDD Article About Exploring the Gut Microbiome’s Role in Drug-Induced Photosensitivity: A Need for Deeper Investigation

Exploring the Gut Microbiome’s Role in Drug-Induced Photosensitivity: A Need for Deeper Investigation

| Featured Articles, Latest News, The Latest | No Comments
Is Your Patient’s Gut Making Their Skin More Sensitive to the Sun? Drug-induced photosensitivity is nothing new, but could the gut microbiome be influencing how severely patients react to sunlight?…
Journal of Drugs in Dermatology JDD Article About Considerations on Concurrent Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Isotretinoin

Considerations on Concurrent Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Isotretinoin

| Acne, Featured Articles, Latest News, The Latest | No Comments
GLP-1RAs and Isotretinoin: A Risky Combination? Recent reports on dermatologic side effects of GLP-1 receptor agonists (GLP-1RAs) have prompted a closer look at how these drugs interact with other treatments,…